Home

EDWARD M GILLIS

CIK 1241359 · Senior Vice President, Devices · last filed 2026-07-07

EDWARD M GILLIS is a Senior Vice President, Devices who has filed 12 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for BCDA, was dated Jul 7, 2026. Across all open-market trades the lifetime net is −$6.5K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $42.3K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$42.3K

Companies

2

Total Filings

12

Lifetime Open-Market Net

-$6.5K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BCDA Senior Vice President, Devices 54,126 $0.78 $42.3K -$6.5K 5 2026-07-07
BioCardia, Inc. (BCDAW) Delisted Senior Vice President, Devices 48,857 $0.01 $298 $0 6 2023-06-02

Recent Filings

12 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-07 BCDA Mixed −17,269 -$21.4K EDGAR
2026-07-01 BCDA Grant (A) +39,521 $47.4K EDGAR
2025-12-10 BCDA Mixed +53,250 $73.0K EDGAR
2024-12-26 BCDA Sell (S) −3,257 -$6.5K EDGAR
2024-12-17 BCDA Notice (144) −3,257 -$6.6K EDGAR
2024-10-16 BCDA Mixed −22,648 -$60.0K EDGAR
2023-06-02 BioCardia, Inc. (BCDAW) Delisted Tax (F) −15,512 -$27.5K EDGAR
2023-05-22 BioCardia, Inc. (BCDAW) Delisted Grant (A) +40,490 $68.8K EDGAR
2022-05-18 BioCardia, Inc. (BCDAW) Delisted Tax (F) −12,358 -$16.3K EDGAR
2022-04-18 BioCardia, Inc. (BCDAW) Delisted Grant (A) +30,155 $0 EDGAR
Showing 1–10 of 12
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.